Bacteriophages Therapy Market Analyst Report 2024

Bacteriophages Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Bacteriophages Therapy Market&nbsp;is segmented By Product (Phage Cocktails, Phage sprays, Phage Tablets &amp; Capsules, Others) By Route of Administration (Oral, Topical, Parenteral) By Targeted Bacteria (Staphylococci, Streptococci, Escherichia coli, Other Bacterial Pathogens) By Disease Indication (Urinary Tract Infections, Infected Burn Wounds, Chronic Otitis, Chronic Venous Leg Ulcers, Chronic Rhinosinusitis) By End-User (Hospitals &amp; Clinics, Specialty Centers, Others)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Bacteriophages Therapy Market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

The use of bacteriophages therapeutically to treat pathogenic bacterial illnesses is known as phage therapy. The bacterial infection is stopped when the bacteria produce the viral genome, which impedes the virus&#39;s capacity to function. The infection-causing bacterial cell cannot proliferate and instead creates more phages.

Benefits include a lower chance of adverse effects and bacterial resistance because bacteriophages are far more selective than antibiotics. Since they usually pose little threat to the host organism and other helpful bacteria like the gut microbiota, the likelihood of opportunistic infections is decreased.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product, Route of Administration, Targeted Bacteria, Disease Indication, End User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/bacteriophages-therapy-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Increase in the incidence of infectious diseases

The increase in the prevalence of infectious diseases is expected to drive market growth in the forecast period. Conventional therapies lose their efficacy when germs grow resistant to widely used antibiotics, which raises the expense of healthcare, lengthens hospital stays, and increases fatality rates. Bacteriophage therapy helps in treating the infectious diseases.&nbsp;

According to the World Health Organization in 2023, around 1,80,000 deaths occurred due to burns and their infection due to pathogenic organisms can increase the complexity of the wound conditions. The majority of these occur in low- and middle-income countries and almost two-thirds occur in the WHO African and South-East Asia Regions.

Additionally, according to NIH in 2023, chronic rhinosinusitis is one of the most common chronic diseases that develop as a result of the inflammatory process of the paranasal sinuses. The prevalence of chronic rhinosinusitis ranges from 2% to 16% and is more common in patients aged 18-64 years. Thus, the above factors are expected to drive the market growth.

High cost of development and production&nbsp;

It takes time and effort to isolate, characterize, and optimize certain bacteriophages for target bacteria to develop and produce phage therapy products. This can be a time-consuming and costly procedure that calls for specific knowledge and resources. Smaller businesses find it difficult to get into the market due to the high expense of clinical studies and regulatory constraints. Thus, high costs can hamper the market growth.&nbsp;

<h3>Segment Analysis</h3>

The global bacteriophage therapy market is segmented based on product, route of administration, targeted bacteria, disease indication, end user and region.

The urinary tract infections segment is expected to dominate the market share

The urinary tract infections segment is expected to hold the dominant position in the market growth due to the increase in the prevalence of infections in individuals. For instance, according to the Urology Care Foundation in 2023, It is estimated that around 8 million individuals visit hospitals every year due to Urinary Tract Infections (UTIs).&nbsp;

UTIs are the second most common type of infection in the body. About 10 in 25 women and 3 in 25 men will have symptoms of a UTI during their lifetime. Around 2.5% of all children will get a UTI. UTIs are most common in children under the age of 5 years. Girls are more likely than boys to get a UTI. Thus, the above factors are expected to hold the segment in the dominant position.

<h3>Geographical Analysis</h3>

North America is expected to hold a significant position in the bacteriophages therapy market share 

North America is expected to hold a dominant position in the market growth. This is due to the research and development that is being carried out at several top research institutes and academic centers in North America. This strengthens the body of knowledge and makes it easier for scientists and physicians to work together.&nbsp;

The availability of well-known biotechnology and pharmaceutical companies that are adept at developing and marketing cutting-edge therapies is largely responsible for the availability of phage therapy products.

For instance, in May 2023, the University of Leicester formally opened a state-of-the-art research laboratory dedicated to studying bacteriophages as a means of fighting antibiotic-resistant bacteria. The UK&#39;s first of its kind, the Centre for Phage Research will investigate phage-based treatments for bacterial illnesses as an alternative to antibiotics. Thus, the above factors are expected to drive the market growth in the region during the forecast period.&nbsp;

<h3>COVID-19 Impact Analysis</h3>

COVID-19 has had a negative impact on the market growth. This is due to the shift of research and development activities&nbsp;directed to COVID-19&nbsp;research, which&nbsp;has slowed down the field&#39;s advancement. The pandemic led to resource shortages and economic upheavals that could have affected phage treatment research and development financing. The attention to&nbsp;COVID-19&nbsp;has caused regulatory procedures to be delayed, which might have hampered the approval of phage treatment products.

<h3>Competitive Landscape</h3>

The major global players in the market include Eliava Biopreparation LLC, BiomX Ltd., Phi Therapeutics, TechnoPhage SA, Intralytix, Inc., Locus Biosciences, Inc., Eligo Bioscience, Armata Pharmaceuticals, Inc. among others.

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global bacteriophages therapy market segmentation based on product, route of administration, targeted bacteria, disease indication, end user and region as well as understand key commercial assets and players.</li>
	<li>identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>excel data sheet with numerous data points of the bacteriophages therapy market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global bacteriophages therapy market report would provide approximately 55 tables, 58 figures and 180 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product</li>
		<li>Snippet by Route of Administration</li>
		<li>Snippet by Targeted Bacteria</li>
		<li>Snippet by Disease Indication</li>
		<li>Snippet by End User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increase in the incidence of infectious diseases</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High cost of development and production</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>Phage Cocktails*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Phage Sprays</li>
		<li>Phage Tablets &amp; Capsules</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Route of Administration</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Attractiveness Index, By Route of Administration</li>
		</ol>
		</li>
		<li>Oral*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Topical</li>
		<li>Parenteral</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Targeted Bacteria</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Targeted Bacteria</li>
			<li>Market Attractiveness Index, By Targeted Bacteria</li>
		</ol>
		</li>
		<li>Staphylococci*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Streptococci</li>
		<li>Escherichia coli&nbsp;</li>
		<li>Other Bacterial Pathogens</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Indication</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Attractiveness Index, By Disease Indication</li>
		</ol>
		</li>
		<li>Urinary Tract Infections*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Infected Burn Wounds</li>
		<li>Chronic Otitis</li>
		<li>Chronic Venous Leg Ulcers</li>
		<li>Chronic Rhinosinusitis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Hospitals &amp; Clinics*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Specialty Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Targeted Bacteria</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Targeted Bacteria</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Targeted Bacteria</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>&nbsp;</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Targeted Bacteria</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Targeted Bacteria</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Indication</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Eliava Biopreparation LLC*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>BiomX Ltd., Phi Therapeutics&nbsp;</li>
		<li>TechnoPhage&nbsp;</li>
		<li>Intralytix, Inc.&nbsp;</li>
		<li>Locus Biosciences, Inc.&nbsp;</li>
		<li>TechnoPhage SA</li>
		<li>Eligo Bioscience&nbsp;</li>
		<li>Armata Pharmaceuticals, Inc.&nbsp;&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Bacteriophages Therapy Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Bacteriophages Therapy Market Value, By Route of Administration, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Bacteriophages Therapy Market Value, By Targeted Bacteria, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Bacteriophages Therapy Market Value, By Disease Indication, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Bacteriophages Therapy Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Bacteriophages Therapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 7 Global Bacteriophages Therapy Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Bacteriophages Therapy Market Value, By Product, 2022-2031 (US$ Million)

Table 9 Global Bacteriophages Therapy Market Value, By Route of Administration, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Bacteriophages Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 11 Global Bacteriophages Therapy Market Value, By Targeted Bacteria, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Bacteriophages Therapy Market Value, By Targeted Bacteria, 2022-2031 (US$ Million)

Table 13 Global Bacteriophages Therapy Market Value, By Disease Indication, 2023, 2027 &amp; 2031 (US$ Million)

Table 14 Global Bacteriophages Therapy Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 15 Global Bacteriophages Therapy Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 16 Global Bacteriophages Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 17 Global Bacteriophages Therapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 18 Global Bacteriophages Therapy Market Value, By Region, 2022-2031 (US$ Million)

Table 19 North America Bacteriophages Therapy Market Value, By Product, 2022-2031 (US$ Million)

Table 20 North America Bacteriophages Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 21 North America Bacteriophages Therapy Market Value, By Targeted Bacteria, 2022-2031 (US$ Million)

Table 22 North America Bacteriophages Therapy Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 23 North America Bacteriophages Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 North America Bacteriophages Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 25 South America Bacteriophages Therapy Market Value, By Product, 2022-2031 (US$ Million)

Table 26 South America Bacteriophages Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 27 South America Bacteriophages Therapy Market Value, By Targeted Bacteria, 2022-2031 (US$ Million)

Table 28 South America Bacteriophages Therapy Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 29 South America Bacteriophages Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 South America Bacteriophages Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Europe Bacteriophages Therapy Market Value, By Product, 2022-2031 (US$ Million)

Table 32 Europe Bacteriophages Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 33 Europe Bacteriophages Therapy Market Value, By Targeted Bacteria, 2022-2031 (US$ Million)

Table 34 Europe Bacteriophages Therapy Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 35 Europe Bacteriophages Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 36 Europe Bacteriophages Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 37 Asia-Pacific Bacteriophages Therapy Market Value, By Product, 2022-2031 (US$ Million)

Table 38 Asia-Pacific Bacteriophages Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 39 Asia-Pacific Bacteriophages Therapy Market Value, By Targeted Bacteria, 2022-2031 (US$ Million)

Table 40 Asia-Pacific Bacteriophages Therapy Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 41 Asia-Pacific Bacteriophages Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 42 Asia-Pacific Bacteriophages Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 43 Middle East &amp; Africa Bacteriophages Therapy Market Value, By Product, 2022-2031 (US$ Million)

Table 44 Middle East &amp; Africa Bacteriophages Therapy Market Value, By Route of Administration, 2022-2031 (US$ Million)

Table 45 Middle East &amp; Africa Bacteriophages Therapy Market Value, By Targeted Bacteria, 2022-2031 (US$ Million)

Table 46 Middle East &amp; Africa Bacteriophages Therapy Market Value, By Disease Indication, 2022-2031 (US$ Million)

Table 47 Middle East &amp; Africa Bacteriophages Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 48 Eliava Biopreparation LLC: Overview

Table 49 Eliava Biopreparation LLC: Product Portfolio

Table 50 Eliava Biopreparation LLC: Key Developments

Table 51 BiomX Ltd., Phi Therapeutics: Overview

Table 52 BiomX Ltd., Phi Therapeutics: Product Portfolio

Table 53 BiomX Ltd., Phi Therapeutics: Key Developments

Table 54 TechnoPhage: Overview

Table 55 TechnoPhage: Product Portfolio

Table 56 TechnoPhage: Key Developments

Table 57 Intralytix, Inc.: Overview

Table 58 Intralytix, Inc.: Product Portfolio

Table 59 Intralytix, Inc.: Key Developments

Table 60 Locus Biosciences, Inc.: Overview

Table 61 Locus Biosciences, Inc.: Product Portfolio

Table 62 Locus Biosciences, Inc.: Key Developments

Table 63 TechnoPhage SA: Overview

Table 64 TechnoPhage SA: Product Portfolio

Table 65 TechnoPhage SA: Key Developments

Table 66 Eligo Bioscience: Overview

Table 67 Eligo Bioscience: Product Portfolio

Table 68 Eligo Bioscience: Key Developments

Table 69 Armata Pharmaceuticals, Inc.: Overview

Table 70 Armata Pharmaceuticals, Inc.: Product Portfolio

Table 71 Armata Pharmaceuticals, Inc.: Key Developments

List of Figures

Figure 1 Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 2 Global Bacteriophages Therapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 3 Global Bacteriophages Therapy Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 4 Global Bacteriophages Therapy Market Share, By Targeted Bacteria, 2023 &amp; 2031 (%)

Figure 5 Global Bacteriophages Therapy Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 6 Global Bacteriophages Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 7 Global Bacteriophages Therapy Market Share, By Region, 2023 &amp; 2031 (%)

Figure 8 Global Bacteriophages Therapy Market Y-o-Y Growth, By Product, 2023-2031 (%)

Figure 9 Phage Cocktails Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 10 Phage Sprays Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 11 Phage Tablets &amp; Capsules Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 12 Others Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 13 Global Bacteriophages Therapy Market Y-o-Y Growth, By Route of Administration, 2023-2031 (%)

Figure 14 Oral Route of Administration in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 15 Topical Route of Administration in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 16 Parenteral Route of Administration in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 17 Global Bacteriophages Therapy Market Y-o-Y Growth, By Targeted Bacteria, 2023-2031 (%)

Figure 18 Staphylococci Targeted Bacteria in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 19 Streptococci Targeted Bacteria in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 20 Escherichia coli Targeted Bacteria in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 21 Other Bacterial Pathogens Targeted Bacteria in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 22 Global Bacteriophages Therapy Market Y-o-Y Growth, By Disease Indication, 2023-2031 (%)

Figure 23 Urinary Tract Infections Disease Indication in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 24 Infected Burn Wounds Disease Indication in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 25 Chronic Otitis Disease Indication in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 26 Chronic Venous Leg Ulcers Disease Indication in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 27 Chronic Rhinosinusitis Disease Indication in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 28 Global Bacteriophages Therapy Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 29 Hospitals &amp; Clinics End-User in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 30 Specialty Centers End-User in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 31 Others End-User in Global Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 32 Global Bacteriophages Therapy Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 33 North America Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 34 Asia-Pacific Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 35 Europe Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 36 South America Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 37 Middle East and Africa Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 38 North America Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 39 North America Bacteriophages Therapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 40 North America Bacteriophages Therapy Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 41 North America Bacteriophages Therapy Market Share, By Targeted Bacteria, 2023 &amp; 2031 (%)

Figure 42 North America Bacteriophages Therapy Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 43 North America Bacteriophages Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 44 North America Bacteriophages Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 45 South America Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 46 South America Bacteriophages Therapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 47 South America Bacteriophages Therapy Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 48 South America Bacteriophages Therapy Market Share, By Targeted Bacteria, 2023 &amp; 2031 (%)

Figure 49 South America Bacteriophages Therapy Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 50 South America Bacteriophages Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 51 South America Bacteriophages Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 52 Europe Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 53 Europe Bacteriophages Therapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 54 Europe Bacteriophages Therapy Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 55 Europe Bacteriophages Therapy Market Share, By Targeted Bacteria, 2023 &amp; 2031 (%)

Figure 56 Europe Bacteriophages Therapy Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 57 Europe Bacteriophages Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 58 Europe Bacteriophages Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 59 Asia-Pacific Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 60 Asia-Pacific Bacteriophages Therapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 61 Asia-Pacific Bacteriophages Therapy Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 62 Asia-Pacific Bacteriophages Therapy Market Share, By Targeted Bacteria, 2023 &amp; 2031 (%)

Figure 63 Asia-Pacific Bacteriophages Therapy Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 64 Asia-Pacific Bacteriophages Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 65 Asia-Pacific Bacteriophages Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 66 Middle East &amp; Africa Bacteriophages Therapy Market Value, 2022-2031 (US$ Million)

Figure 67 Middle East &amp; Africa Bacteriophages Therapy Market Share, By Product, 2023 &amp; 2031 (%)

Figure 68 Middle East &amp; Africa Bacteriophages Therapy Market Share, By Route of Administration, 2023 &amp; 2031 (%)

Figure 69 Middle East &amp; Africa Bacteriophages Therapy Market Share, By Targeted Bacteria, 2023 &amp; 2031 (%)

Figure 70 Middle East &amp; Africa Bacteriophages Therapy Market Share, By Disease Indication, 2023 &amp; 2031 (%)

Figure 71 Middle East &amp; Africa Bacteriophages Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 72 Eliava Biopreparation LLC: Financials

Figure 73 BiomX Ltd., Phi Therapeutics: Financials

Figure 74 TechnoPhage: Financials

Figure 75 Intralytix, Inc.: Financials

Figure 76 Locus Biosciences, Inc.: Financials

Figure 77 TechnoPhage SA: Financials

Figure 78 Eligo Bioscience: Financials

Figure 79 Armata Pharmaceuticals, Inc.: Financials

Bacteriophages Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Bacterial Infectious Diseases Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 19

Starting from

mRNA Vaccine and Therapeutics Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 December 19

Starting from